Arcturus Therapeutics Holdings (ARCT) Total Liabilities: 2018-2025
Historic Total Liabilities for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Sep 2025 value amounting to $57.8 million.
- Arcturus Therapeutics Holdings' Total Liabilities fell 46.88% to $57.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.8 million, marking a year-over-year decrease of 46.88%. This contributed to the annual value of $103.1 million for FY2024, which is 31.68% down from last year.
- Arcturus Therapeutics Holdings' Total Liabilities amounted to $57.8 million in Q3 2025, which was down 26.12% from $78.2 million recorded in Q2 2025.
- Arcturus Therapeutics Holdings' Total Liabilities' 5-year high stood at $180.1 million during Q4 2022, with a 5-year trough of $57.8 million in Q3 2025.
- Its 3-year average for Total Liabilities is $122.4 million, with a median of $130.0 million in 2024.
- As far as peak fluctuations go, Arcturus Therapeutics Holdings' Total Liabilities skyrocketed by 188.08% in 2021, and later crashed by 46.88% in 2025.
- Quarterly analysis of 5 years shows Arcturus Therapeutics Holdings' Total Liabilities stood at $164.6 million in 2021, then grew by 9.40% to $180.1 million in 2022, then decreased by 16.21% to $150.9 million in 2023, then crashed by 31.68% to $103.1 million in 2024, then slumped by 46.88% to $57.8 million in 2025.
- Its Total Liabilities stands at $57.8 million for Q3 2025, versus $78.2 million for Q2 2025 and $98.0 million for Q1 2025.